Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: May 14, 2004
Last updated: June 18, 2013
Last verified: December 2005
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2006
  Estimated Primary Completion Date: No date given